Navigation Links
Southeast Asian Children With Leukaemia To Get New Treatment

According to experts a hospital in US is all set to use Singapore as a base in order to treat the children, who are suffering from leukaemia// , of the developing Southeast Asian countries.

The breakthrough enables the bone marrow cells of the parents to be used in the transplants the children need.

"We already have the facilities to purify the cells here," The Straits Times quoted Allen Yeoh, senior consultant at the National University Hospital (NUH), as saying.

The method, known as haploidentical transplantation, is aimed at children who need transplants but cannot find suitable matches.

Previously it was considered that a parent's bone marrow could not be used because it was too different from the child.

Scientists at the St. Jude Children's Research Hospital in Memphis, Tennessee, have found a way to remove the strongest immune cells from the parent's bone marrow cells before transplanting them, allowing the child's body to accept them.

St. Jude is helping the NUH set up such a service in Singapore in a year's time.

The procedures have helped make St. Jude's remission rate for childhood leukaemia one of the best in the world, at 90 percent. NUH is hoping to improve its 80 percent rate.

Ching-Hon Pui, St. Jude's chairman of oncology, noted that leukaemia cure rates were between four percent and 55 percent in developing countries.

"Through this unique partnership, we can help many other children with cancer in Southeast Asia" and conduct collaborative research, he told the newspaper.

--Edited IANS
'"/>




Page: 1

Related medicine news :

1. Smoking Banned In Southeast Asian Games Venues
2. Regional Cooperation Promoted in Southeast Asia
3. Mediterranean diet aids Asian masses
4. Who Board To Discuss Asian Tsunami Related Health Issues
5. SARS (Bird Flu) spreading in the Asian continent
6. Hepatitis B A high cause of Asian Female Mortality
7. Smoking Banned In Southeast Asian Games Venues
8. Asian Alternative Treatments For Cancer On The Rise In Europe
9. More Funds required for Asian Countries to fight Bird Flu
10. Asian Nations Told To Ready Themselves For Pandemic
11. Asian Doctors Caught Issuing False Sick Notes
Post Your Comments:
(Date:12/6/2009)... advised to avoid oysters harvested from San Antonio Bay ... The U.S. Food and Drug Administration is advising consumers ... Bay on or after Nov. 16 due to reports ... oysters harvested from this area, which is located on ... http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ,, The FDA, along with the ...
(Date:12/6/2009)... that the loss of a key segment of DNA can ... to show that this kind of genetic alteration can cause ... , The study, led by Dr Sadaf Farooqi from the ... Trust Sanger Institute, looked at 300 children with severe obesity. ... types of mutation known as copy number variants (CNVs). CNVs ...
(Date:12/6/2009)... feline DNA in virus , , SUNDAY, Dec. 6 (HealthDay News) ... be found in a tiger that lived thousands or millions ... the virus took on a bit of a tiger,s genetic ... in the virus to this day. That tiger, in fact, ... the virus that ultimately led to its infection of humans. ...
(Date:12/6/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ... pivotal Phase 2b 003-A1 study, known as the ... heavily pre-treated relapsed and refractory multiple myeloma patients. ... Joint Symposium at the 51st annual meeting of ... Orleans. Enrollment in this trial is complete (n=269), ...
(Date:12/6/2009)... Dec. 6 Blood clotting, or coagulation, ... when a blood vessel is injured. Sometimes, however, ... an obvious injury or do not dissolve naturally, ... today at the 51st Annual Meeting of the ... of using the anticoagulants aspirin and heparin with ...
Breaking Medicine News(10 mins):Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:AIDS May Date Back to Ancient Tiger 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7
... who do drop risk of premature birth, smaller babies ... who quit smoking before the 15th week of pregnancy ... babies to that of nonsmoking women, a new study ... the risk of miscarriage, ectopic pregnancy, premature birth, small ...
... Hancock Medical Center for Making Quality of Care "No. 1 Priority" ... ... in Bay Saint Louis, Miss., was named Mississippi Hospital of the ... Awards on March 2. The hospital, a QHR management client ...
... Pregis Corporation, a leading international manufacturer, marketer, and ... today announced its 2008 fourth quarter and full year ... generated net sales of $219.6 million, a decrease of ... fourth quarter of 2007. Excluding incremental revenue from ...
... Study finds it suppresses enzyme vital to tumor growth , , ... combat AIDS may also help slow the spread of a ... , A study published in the current issue of the ... suppresses the enzyme telomerase. Telomerase activity appears to be essential ...
... Health and Safety and Pharmaceutical Innovation First ... Pharmaceutical Association (GPhA) released the following statement ... Jaeger regarding the bipartisan Senate introduction of ... Medicine Act.""Momentum is skyrocketing for biogenerics legislation ...
... common drugs, study finds , , THURSDAY, March 26 (HealthDay ... can be triggered by some commonly used heart medications, ... the condition followed injections of adrenaline or dobutamine, according ... issue of the Journal of the American College ...
Other Medicine News:Health News:Newly Pregnant Smokers Have a 15-Week Window to Quit 2Health News:QHR Management Client Hancock Medical Center Named Mississippi Hospital of the Year 2Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 2Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 3Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 4Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 5Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 6Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 7Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 8Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 9Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 10Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 11Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 12Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 13Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 14Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 15Health News:GPhA Statement on the Introduction of the Bipartisan Senate Biogenerics Consensus Bill: 'Promoting Innovation and Access to Life-Saving Medicine Act' 2Health News:What Causes Mystery Heart Condition? 2Health News:What Causes Mystery Heart Condition? 3
(Date:12/7/2009)... /PRNewswire-Asia/ -- TaiGen Biotechnology Co., Ltd.,announced today ... data for TG-0054,the Company,s chemokine receptor CXCR4 ... at the ASH Annual Meeting held in ... 8, 2009. , ... will be presented. In this randomized,double-blind, placebo-controlled, ...
(Date:12/7/2009)... RAPIDS, Mich., Dec. 7 On December ... on its eight-story, $178 million, 240,000 square foot ... and scientific opportunity both for VAI and West ... the more than $1 billion investment in infrastructure ... When operating at capacity, the expansion will support ...
(Date:12/7/2009)... ,, 60 people, males and females, ... antibodies generated by the vaccine specifically identified several ... BiondVax,s CEO Dr. Ron Babecoff: "This is ... realization of the Company,s vision of ensuring protection ... , BiondVax Pharmaceuticals Ltd. (TASE: ...
Breaking Medicine Technology:TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 3Van Andel Institute Cuts Ribbon on $178 Million Expansion 4Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 2Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 3Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 4Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 5XELR8 Holdings Inc Hires Vice President of Strategy and Network Development 48585 1XELR8 Holdings Inc Hires Vice President of Strategy and Network Development 48585 2XELR8 Holdings Inc Hires Vice President of Strategy and Network Development 48585 3New From the Heinz Family Philanthropies 3A 10 Questions and Valuable Answers to Help Families If They Are Not Happy With Their Long Term Care 48581 1New From the Heinz Family Philanthropies 3A 10 Questions and Valuable Answers to Help Families If They Are Not Happy With Their Long Term Care 48581 2New From the Heinz Family Philanthropies 3A 10 Questions and Valuable Answers to Help Families If They Are Not Happy With Their Long Term Care 48581 3New From the Heinz Family Philanthropies 3A 10 Questions and Valuable Answers to Help Families If They Are Not Happy With Their Long Term Care 48581 4New From the Heinz Family Philanthropies 3A 10 Questions and Valuable Answers to Help Families If They Are Not Happy With Their Long Term Care 48581 5New From the Heinz Family Philanthropies 3A 10 Questions and Valuable Answers to Help Families If They Are Not Happy With Their Long Term Care 48581 6First and Only Weaning Product Based on 100 25 Non Allergenic Amino Acids Specifically Designed for Children With Cows Milk Protein Allergy and Multip 48577 1First and Only Weaning Product Based on 100 25 Non Allergenic Amino Acids Specifically Designed for Children With Cows Milk Protein Allergy and Multip 48577 2First and Only Weaning Product Based on 100 25 Non Allergenic Amino Acids Specifically Designed for Children With Cows Milk Protein Allergy and Multip 48577 3
... and data management system ,RADIANCE is ... needs of data management systems (DMS), and ... of STAT analyzer systems., ,The RADIANCE software ... for both STAT analyzers and hospital and ...
... syngo Dynamics network is ... and archiving system using evidence-based ... of clinical procedures. It has ... practical reality for hospital echocardiography ...
... AXIOM Artis dTC is a versatile ... the cardiology department from preparation to ... interventional procedures. With AXIOM Artis dTC, your ... the cardiology department that leaves you free ...
... ACUSON Cypress cardiovascular system ... worlds first portable, high-performance transesophageal ... highly miniaturized, all-digital, phased array ... studies and outstanding images, even ...
Medicine Products: